Compare RZLT & GILT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RZLT | GILT |
|---|---|---|
| Founded | 2010 | 1987 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.3M | 747.5M |
| IPO Year | N/A | 1993 |
| Metric | RZLT | GILT |
|---|---|---|
| Price | $1.91 | $11.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $12.33 | ★ $16.00 |
| AVG Volume (30 Days) | ★ 12.2M | 497.8K |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 42.22 |
| EPS | N/A | ★ 0.41 |
| Revenue | N/A | ★ $392,826,000.00 |
| Revenue This Year | N/A | $49.48 |
| Revenue Next Year | N/A | $13.61 |
| P/E Ratio | ★ N/A | $27.45 |
| Revenue Growth | N/A | ★ 29.68 |
| 52 Week Low | $1.07 | $5.30 |
| 52 Week High | $11.46 | $15.24 |
| Indicator | RZLT | GILT |
|---|---|---|
| Relative Strength Index (RSI) | 24.74 | 41.10 |
| Support Level | $1.07 | $11.28 |
| Resistance Level | $2.25 | $13.08 |
| Average True Range (ATR) | 0.64 | 0.49 |
| MACD | -0.87 | -0.00 |
| Stochastic Oscillator | 7.83 | 5.09 |
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.
Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs), and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.